BE633375A - - Google Patents
Info
- Publication number
- BE633375A BE633375A BE633375DA BE633375A BE 633375 A BE633375 A BE 633375A BE 633375D A BE633375D A BE 633375DA BE 633375 A BE633375 A BE 633375A
- Authority
- BE
- Belgium
- Prior art keywords
- cells
- bacteria
- vaccine
- lysis
- antigenic
- Prior art date
Links
- 229960005486 vaccines Drugs 0.000 claims description 98
- 210000004027 cells Anatomy 0.000 claims description 47
- 241000894006 Bacteria Species 0.000 claims description 44
- 230000009089 cytolysis Effects 0.000 claims description 37
- 230000002934 lysing Effects 0.000 claims description 37
- 230000000890 antigenic Effects 0.000 claims description 30
- 108090000790 Enzymes Proteins 0.000 claims description 29
- 102000004190 Enzymes Human genes 0.000 claims description 29
- 238000010438 heat treatment Methods 0.000 claims description 14
- 238000000034 method Methods 0.000 claims description 13
- 239000000203 mixture Substances 0.000 claims description 11
- 210000001938 protoplasts Anatomy 0.000 claims description 11
- 241000283690 Bos taurus Species 0.000 claims description 10
- 208000004396 Mastitis Diseases 0.000 claims description 10
- 241000295644 Staphylococcaceae Species 0.000 claims description 10
- DHMQDGOQFOQNFH-UHFFFAOYSA-N glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 claims description 10
- 238000002360 preparation method Methods 0.000 claims description 9
- 241000607142 Salmonella Species 0.000 claims description 8
- 241000293871 Salmonella enterica subsp. enterica serovar Typhi Species 0.000 claims description 8
- 206010039447 Salmonellosis Diseases 0.000 claims description 8
- 239000000654 additive Substances 0.000 claims description 8
- 230000002797 proteolythic Effects 0.000 claims description 8
- 230000000996 additive Effects 0.000 claims description 6
- 230000002779 inactivation Effects 0.000 claims description 6
- 230000001717 pathogenic Effects 0.000 claims description 6
- 239000004471 Glycine Substances 0.000 claims description 5
- 235000001014 amino acid Nutrition 0.000 claims description 5
- 150000001413 amino acids Chemical class 0.000 claims description 5
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 claims description 3
- 235000004279 alanine Nutrition 0.000 claims description 3
- 230000003053 immunization Effects 0.000 claims description 3
- 241000191967 Staphylococcus aureus Species 0.000 claims description 2
- 229940076185 Staphylococcus aureus Drugs 0.000 claims description 2
- 239000000080 wetting agent Substances 0.000 claims description 2
- 241000588832 Bordetella pertussis Species 0.000 claims 2
- 229940052491 Bordetella pertussis Drugs 0.000 claims 2
- 201000008827 tuberculosis Diseases 0.000 claims 2
- 238000011065 in-situ storage Methods 0.000 claims 1
- 229920001098 polystyrene-block-poly(ethylene/propylene) Polymers 0.000 description 62
- 239000000725 suspension Substances 0.000 description 15
- 229940110715 ENZYMES FOR TREATMENT OF WOUNDS AND ULCERS Drugs 0.000 description 12
- 229940114721 Enzymes FOR DISORDERS OF THE MUSCULO-SKELETAL SYSTEM Drugs 0.000 description 12
- 229940093738 Enzymes for ALIMENTARY TRACT AND METABOLISM Drugs 0.000 description 12
- 229940019336 antithrombotic Enzymes Drugs 0.000 description 12
- 229940020899 hematological Enzymes Drugs 0.000 description 12
- 229940083249 peripheral vasodilators Enzymes Drugs 0.000 description 12
- 230000001580 bacterial Effects 0.000 description 9
- 239000002609 media Substances 0.000 description 9
- JUJWROOIHBZHMG-UHFFFAOYSA-N pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 8
- 229940088598 Enzyme Drugs 0.000 description 7
- 201000009910 diseases by infectious agent Diseases 0.000 description 7
- 239000006166 lysate Substances 0.000 description 7
- 230000000392 somatic Effects 0.000 description 7
- 239000000126 substance Substances 0.000 description 7
- 210000002966 Serum Anatomy 0.000 description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- 201000008297 typhoid fever Diseases 0.000 description 6
- 229920001817 Agar Polymers 0.000 description 5
- 239000000427 antigen Substances 0.000 description 5
- 108091007172 antigens Proteins 0.000 description 5
- 102000038129 antigens Human genes 0.000 description 5
- 239000003795 chemical substances by application Substances 0.000 description 5
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 5
- FAPWRFPIFSIZLT-UHFFFAOYSA-M sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 5
- 241000304886 Bacilli Species 0.000 description 4
- 210000002421 Cell Wall Anatomy 0.000 description 4
- 241000206672 Gelidium Species 0.000 description 4
- 241001465754 Metazoa Species 0.000 description 4
- FPKOPBFLPLFWAD-UHFFFAOYSA-N Trinitrotoluene Chemical compound CC1=CC=C([N+]([O-])=O)C([N+]([O-])=O)=C1[N+]([O-])=O FPKOPBFLPLFWAD-UHFFFAOYSA-N 0.000 description 4
- 235000010419 agar Nutrition 0.000 description 4
- 102000004965 antibodies Human genes 0.000 description 4
- 108090001123 antibodies Proteins 0.000 description 4
- 230000015572 biosynthetic process Effects 0.000 description 4
- 238000005755 formation reaction Methods 0.000 description 4
- 230000036512 infertility Effects 0.000 description 4
- 239000011780 sodium chloride Substances 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- 231100000803 sterility Toxicity 0.000 description 4
- 238000005406 washing Methods 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- 241000283973 Oryctolagus cuniculus Species 0.000 description 3
- 231100000765 Toxin Toxicity 0.000 description 3
- HWKQNAWCHQMZHK-UHFFFAOYSA-N Trolnitrate Chemical compound [O-][N+](=O)OCCN(CCO[N+]([O-])=O)CCO[N+]([O-])=O HWKQNAWCHQMZHK-UHFFFAOYSA-N 0.000 description 3
- 102000004142 Trypsin Human genes 0.000 description 3
- 108090000631 Trypsin Proteins 0.000 description 3
- 239000000440 bentonite Substances 0.000 description 3
- 229910000278 bentonite Inorganic materials 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 230000002265 prevention Effects 0.000 description 3
- 230000001681 protective Effects 0.000 description 3
- KEAYESYHFKHZAL-UHFFFAOYSA-N sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 3
- 239000011734 sodium Substances 0.000 description 3
- 229910052708 sodium Inorganic materials 0.000 description 3
- 239000003053 toxin Substances 0.000 description 3
- 108020003112 toxins Proteins 0.000 description 3
- 229960001322 trypsin Drugs 0.000 description 3
- 239000012588 trypsin Substances 0.000 description 3
- 229940064005 Antibiotic throat preparations Drugs 0.000 description 2
- 229940083879 Antibiotics FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE Drugs 0.000 description 2
- 229940042052 Antibiotics for systemic use Drugs 0.000 description 2
- 229940042786 Antitubercular Antibiotics Drugs 0.000 description 2
- 229960001212 BACTERIAL VACCINES Drugs 0.000 description 2
- 241000588807 Bordetella Species 0.000 description 2
- 229940093922 Gynecological Antibiotics Drugs 0.000 description 2
- 102000016943 Muramidase Human genes 0.000 description 2
- 108010014251 Muramidase Proteins 0.000 description 2
- 229940049954 Penicillin Drugs 0.000 description 2
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 2
- 102000035443 Peptidases Human genes 0.000 description 2
- 108091005771 Peptidases Proteins 0.000 description 2
- 229940024999 Proteolytic enzymes for treatment of wounds and ulcers Drugs 0.000 description 2
- 229940024982 Topical Antifungal Antibiotics Drugs 0.000 description 2
- 241001467018 Typhis Species 0.000 description 2
- 206010061393 Typhus Diseases 0.000 description 2
- 206010068760 Ulcers Diseases 0.000 description 2
- 238000009632 agar plate Methods 0.000 description 2
- 239000003242 anti bacterial agent Substances 0.000 description 2
- 229960000626 benzylpenicillin Drugs 0.000 description 2
- 230000003115 biocidal Effects 0.000 description 2
- 239000006161 blood agar Substances 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 229920003013 deoxyribonucleic acid Polymers 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- WSFSSNUMVMOOMR-UHFFFAOYSA-N formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 2
- 229940079866 intestinal antibiotics Drugs 0.000 description 2
- 229960000274 lysozyme Drugs 0.000 description 2
- 239000004325 lysozyme Substances 0.000 description 2
- 235000010335 lysozyme Nutrition 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 235000013372 meat Nutrition 0.000 description 2
- 239000006916 nutrient agar Substances 0.000 description 2
- 229940005935 ophthalmologic Antibiotics Drugs 0.000 description 2
- 230000002829 reduced Effects 0.000 description 2
- 231100000486 side effect Toxicity 0.000 description 2
- 235000011121 sodium hydroxide Nutrition 0.000 description 2
- 241000894007 species Species 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- 239000004094 surface-active agent Substances 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- 238000005429 turbidity Methods 0.000 description 2
- 231100000397 ulcer Toxicity 0.000 description 2
- 208000006673 Asthma Diseases 0.000 description 1
- 241000700198 Cavia Species 0.000 description 1
- 210000000170 Cell Membrane Anatomy 0.000 description 1
- 206010010071 Coma Diseases 0.000 description 1
- 241000186216 Corynebacterium Species 0.000 description 1
- 101710034658 DNASE1 Proteins 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N HCl Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 1
- 210000004072 Lung Anatomy 0.000 description 1
- 241000283898 Ovis Species 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 241000531795 Salmonella enterica subsp. enterica serovar Paratyphi A Species 0.000 description 1
- 241000607768 Shigella Species 0.000 description 1
- 206010040550 Shigella infection Diseases 0.000 description 1
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 1
- 239000004141 Sodium laurylsulphate Substances 0.000 description 1
- 229940105648 Soma Drugs 0.000 description 1
- 241000191940 Staphylococcus Species 0.000 description 1
- 206010061372 Streptococcal infection Diseases 0.000 description 1
- 240000000054 Tropaeolum tuberosum Species 0.000 description 1
- 235000018963 Tropaeolum tuberosum Nutrition 0.000 description 1
- 241000233948 Typha Species 0.000 description 1
- 229960000155 Typhoid Vaccines Drugs 0.000 description 1
- 229960001266 Typhoid vaccines Drugs 0.000 description 1
- 241000607626 Vibrio cholerae Species 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000016383 Zea mays subsp huehuetenangensis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 230000001154 acute Effects 0.000 description 1
- 230000000240 adjuvant Effects 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 239000003463 adsorbent Substances 0.000 description 1
- 231100000494 adverse effect Toxicity 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 229920002892 amber Polymers 0.000 description 1
- 230000000844 anti-bacterial Effects 0.000 description 1
- 235000020127 ayran Nutrition 0.000 description 1
- 239000003899 bactericide agent Substances 0.000 description 1
- CURLTUGMZLYLDI-UHFFFAOYSA-N carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 125000002091 cationic group Chemical group 0.000 description 1
- 239000003518 caustics Substances 0.000 description 1
- 239000006285 cell suspension Substances 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000000356 contaminant Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 125000000853 cresyl group Chemical class C1(=CC=C(C=C1)C)* 0.000 description 1
- 230000004059 degradation Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 230000001627 detrimental Effects 0.000 description 1
- 238000000502 dialysis Methods 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 229910000041 hydrogen chloride Inorganic materials 0.000 description 1
- 238000002649 immunization Methods 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 230000000415 inactivating Effects 0.000 description 1
- 238000011081 inoculation Methods 0.000 description 1
- 239000002054 inoculum Substances 0.000 description 1
- 238000007918 intramuscular administration Methods 0.000 description 1
- 230000002147 killing Effects 0.000 description 1
- 230000001665 lethal Effects 0.000 description 1
- 231100000518 lethal Toxicity 0.000 description 1
- 244000144972 livestock Species 0.000 description 1
- 235000009973 maize Nutrition 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 235000008935 nutritious Nutrition 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 150000002960 penicillins Chemical class 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 1
- 229920000053 polysorbate 80 Polymers 0.000 description 1
- 238000002203 pretreatment Methods 0.000 description 1
- 230000002035 prolonged Effects 0.000 description 1
- 229910052704 radon Inorganic materials 0.000 description 1
- SYUHGPGVQRZVTB-UHFFFAOYSA-N radon(0) Chemical compound [Rn] SYUHGPGVQRZVTB-UHFFFAOYSA-N 0.000 description 1
- 230000000717 retained Effects 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 239000010414 supernatant solution Substances 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 239000008399 tap water Substances 0.000 description 1
- 235000020679 tap water Nutrition 0.000 description 1
- 239000001973 thioglycolate broth Substances 0.000 description 1
- 239000007143 thioglycolate medium Substances 0.000 description 1
- 210000001519 tissues Anatomy 0.000 description 1
- 231100000820 toxicity test Toxicity 0.000 description 1
- 230000001131 transforming Effects 0.000 description 1
- 238000002255 vaccination Methods 0.000 description 1
- 230000003313 weakening Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Publications (1)
Publication Number | Publication Date |
---|---|
BE633375A true BE633375A (US06486227-20021126-C00005.png) |
Family
ID=200952
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BE633375D BE633375A (US06486227-20021126-C00005.png) |
Country Status (1)
Country | Link |
---|---|
BE (1) | BE633375A (US06486227-20021126-C00005.png) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2446111A1 (fr) * | 1979-01-12 | 1980-08-08 | Hours Michel | Procede de preparation d'antigenes et vaccins obtenus selon ce procede |
EP0255755A2 (en) * | 1986-06-05 | 1988-02-10 | Baylor College of Medicine | Vaccine preparation |
-
0
- BE BE633375D patent/BE633375A/fr unknown
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2446111A1 (fr) * | 1979-01-12 | 1980-08-08 | Hours Michel | Procede de preparation d'antigenes et vaccins obtenus selon ce procede |
EP0255755A2 (en) * | 1986-06-05 | 1988-02-10 | Baylor College of Medicine | Vaccine preparation |
EP0255755A3 (en) * | 1986-06-05 | 1988-05-25 | Baylor College of Medicine | Vaccine preparation |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Sanders et al. | Renibacterium salmoninarum gen. nov., sp. nov., the causative agent of bacterial kidney disease in salmonid fishes | |
EP0302781B1 (fr) | Procédé d'obtention de polyosides capsulaires de staphylocoques, applications de ces polyosides et souches pour la mise en oeuvre du procédé | |
US10918680B2 (en) | Phage therapy of E coli infections | |
FR2468372A1 (fr) | Nouveau vaccin contre les maladies infectieuses chez les bovins et son procede de production | |
CA2210928A1 (fr) | Proteines de mycobacteries, microorganismes les produisant et leurs utilisations vaccinales et pour la detection de la tuberculose | |
Skerman et al. | Differentiation of Bacteroides nodosus biotypes and colony variants in relation to their virulence and immunoprotective properties in sheep | |
US5688682A (en) | Method for producing a bacterial vaccine and novel vaccines produced thereby | |
EP0037522B1 (fr) | Dérivés de l'entérotoxine thermostable de Escherichia Coli et leur préparation | |
Oslan et al. | Improved stability of live attenuated vaccine gdhA derivative Pasteurella multocida B: 2 by freeze drying method for use as animal vaccine | |
BE633375A (US06486227-20021126-C00005.png) | ||
FR2590172A1 (fr) | Nouvel antigene commun (psc-a) de pseudomonas aeruginosa protegeant contre l'infection provoquee par cet organisme | |
FR2645878A1 (fr) | Sequences nucleotidiques d'actinomycetales, applications a la synthese ou a la detection d'acides nucleiques, produits d'expression de ces sequences et application en tant que compositions immunogenes | |
Mansour et al. | Molecular characterization and immunoprotective activity of capsular polysaccharide of Klebsiella Pneumoniae isolated from farm animals at Taif Governorate | |
CN112218647A (zh) | 赤红球菌产品在治疗热损伤中的用途 | |
CN1174559A (zh) | 摩拉克氏菌的主要外膜蛋白cd | |
CN1112356A (zh) | 新型的减毒铜绿假单胞菌菌株 | |
Serushago et al. | Role of antibodies against outer-membrane proteins in murine resistance to infection with encapsulated Klebsiella pneumoniae | |
JP2000500027A (ja) | パピロマトゥスディジタルデルマティティスの検出、予防及び治療 | |
CN108048364B (zh) | 一种金黄色葡萄球菌及含该菌的海洋哺乳动物疫苗 | |
KR20050008453A (ko) | 결핵 관리에 유용한 약제학적 조성물의 제조방법 | |
CA1251135A (en) | Anti-mastitis polyvalent vaccine, method of administration and method for production thereof | |
BE882619A (fr) | Vaccin pour le controle de la pleuropneumonie chez le porc | |
JPS5953828B2 (ja) | ボルデテラ・プロンヒセブティカ感染症生菌ワクチン用改良原株の作出法および生菌ワクチン | |
FR2607392A1 (fr) | Procede pour la preparation d'une souche mutante de bordetella bronchiseptica utile pour la preparation d'un vaccin vivant attenue pour la prophylaxie des infections a b. bronchiseptica et vaccin vivant attenue contre la rhinite atrophique ainsi prepare | |
FR2571618A1 (fr) | Nouveau vaccin contre la tracheobronchite infectieuse canine et son procede de preparation |